Elevance Health, Inc.
AT ˙ WBAG
SecurityAT:ELV / Elevance Health, Inc.
InstitutionRockland Trust Co
Latest Disclosed Ownership67,160 shares
Latest Disclosed Value $ 19,661,090
Rockland Trust Co reports 4.43% increase in ownership of ELV / Elevance Health, Inc.

On April 16, 2026 - Rockland Trust Co filed a 13F-HR form disclosing ownership of 67,160 shares of Elevance Health, Inc. (AT:ELV) valued at $19,661,090 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 15, 2026 disclosing 64,308 shares of Elevance Health, Inc.. This represents a change in shares of 4.43% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-16 2026-03-31 13F ELEVANCE HEALTH INC FORMERLY COM 036752103 67,160 2,852 4.43 19,661 -12.78 0.7339
2026-01-15 2025-12-31 13F ELEVANCE HEALTH INC FORMERLY COM 036752103 64,308 63,538 8,251.69 22,543 8,989.92 0.8877
2025-11-06 2025-09-30 13F ELEVANCE HEALTH INC FORMERLY COM 036752103 770 3 0.39 249 -16.78 0.0102
2025-07-10 2025-06-30 13F ELEVANCE HEALTH COM 036752103 767 -106 -12.14 298 -21.37 0.0145
2025-04-16 2025-03-31 13F ELEVANCE HEALTH COM 036752103 873 278 46.72 380 73.06 0.0191
2025-01-14 2024-12-31 13F Elevance Health COM 036752103 595 -7 -1.16 219 -30.03 0.0112
2024-10-03 2024-09-30 13F Elevance Health COM 036752103 602 95 18.74 313 14.23 0.0154
2024-07-23 2024-06-30 13F Elevance Health COM 036752103 507 52 11.43 275 16.60 0.0145
2024-04-11 2024-03-31 13F Elevance Health COM 036752103 455 -46 -9.18 236 -0.42 0.0124
2024-01-11 2023-12-31 13F Elevance Health COM 036752103 501 16 3.30 236 11.85 0.0129
2023-10-26 2023-09-30 13F Elevance Health COM 036752103 485 485 211 0.0127
2023-04-24 2023-03-31 13F Elevance Health COM 036752103 0 -495 -100.00 0 0.0000
2023-01-24 2022-12-31 13F Elevance Health COM 036752103 495 -32 -6.07 0 -100.00 0.0161
2022-10-19 2022-09-30 13F Elevance Health COM 036752103 527 25 4.98 239 -1.24 0.0171
2022-07-13 2022-06-30 13F Elevance Health COM 036752103 502 502 242 0.0167
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.